Immuron IMRN
NASDAQ IMRN
$1.25 +0.01 (+1.21%)
At close: Sep 22, 2026 · 4:00 PM EDT

Immuron (IMRN) Cash & Equivalents Growth (5y) (2020 - 2025)

Analysis

Immuron (IMRN) Cash & Equivalents Growth (5y) (2020 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 212.54 Bn 198.55 Bn 7.24 Bn
2 Gilead Sciences 186.84 Bn 183.58 Bn 6.22 Bn
3 Vertex Pharmaceuticals 129.39 Bn 121.54 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.05 Bn 74.06 Bn 3.93 Bn
5 Moderna 69.00 Bn 63.87 Bn 52.00 Mn
6 Argenx Se 61.15 Bn 55.97 Bn 1.37 Bn
7 Alnylam Pharmaceuticals 32.67 Bn 29.37 Bn 992.69 Mn
8 Biogen 32.37 Bn 31.08 Bn 1.96 Bn
9 Roivant Sciences 28.18 Bn 28.87 Bn 1.16 Mn
10 Immuron 7.25 Mn -1.77 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 3.56%
Sep 2, 2025 -61.28%
Jun 30, 2025 -3.18%
Dec 31, 2024 16.86%
Jun 30, 2024 16.46%
Dec 31, 2023 26.92%
Sep 28, 2023 26.59%
Aug 30, 2023 -48.48%
Jun 30, 2023 26.23%
Dec 31, 2022 36.44%
Aug 31, 2022 30.94%
Jun 30, 2022 39.47%
Dec 31, 2021 60.40%
Jun 30, 2021 62.34%
Jun 30, 2020 -2.54%
API Access

Immuron Cash & Equivalents Growth (5y) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents-growth-5y&ticker=IMRN&period=max&api_key=YOUR_API_KEY